Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Investor Presentation (May 2023)
23 slides from Lifemd's investor presentation, May 2023
Slide 1: The Doctor Will See You Now
The Doctor Will See You Now May 2023 NASDAQ: LFMD
Slide 2: Important Cautions Regarding Forward-Looking Statements
NASDAQ: LFMD Important Cautions Regarding Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the
Slide 3: Our Mission
Our Mission Empower people to live healthier lives by increasing access to affordable, high quality virtual and in-home healthcare
Slide 4: LifeMD At A Glance
NASDAQ: LFMD LifeMD At A Glance A transformational year, including new brands and partnerships, heightened focus on subscription-based virtual care platform, and rapidly growing profitability. 200+ 130+ 1 $119m 715k 28% 2022A Patient Conditions Patient Care ’22 Revenue Revenue Consultations Treated
Slide 5: Our Patient-Centric Approach
NASDAQ: LFMD Our Patient- Virtual Care Centric Approach Comprehensive care including primary care, urgent care, and chronic LifeMD's integrative platform elevates the healthcare condition management. experience with seamless, end-to-end care spanning diagnosis, medication delivery, and ongoing care.
Slide 6: Our Growing LifeMD Ecosystem
NASDAQ: LFMD 50-State Telehealth Platform Marketing & E-Commerce Our Growing LifeMD Lab Services Ecosystem Pharmacy Adjudication & Powered by Strong Partners & Integrations Cash-Pay Medications Data & Analytics Customer Service 6
Slide 7: Facilitating The Future Of Virtual-First, In-Home Healthcare
NASDAQ: LFMD Facilitating The Future Of Virtual-First, In-Home Healthcare Advanced Patient Diagnostics & Prescription Symptom Education In-Home Labs Discount Card Checker Robust GLP-1 Supplement Clinical Virtual Consults Weight Loss & Lifestyle Specialist & Messaging Platform Routines Access 7
Slide 8: A Telehealth Platform Trusted By Over 715k Patients
NASDAQ: LFMD A Telehealth Platform Trusted By Over 715k Patients Best-in-Class Marketing & Scalable Providers Data Analytics Technology We attract and invest in Deep expertise in Our vertically integrated amazing medical providers performance marketing, platform is proven to that deliver incredible
Slide 9: Best-In-Class Providers
NASDAQ: LFMD Best-In-Class Providers Health Care Leadership Professionals Deep experience in 50 state coverage virtual and brick-and- by LifeMD affiliated mortar primary and doctors and NPs urgent care Multi-State Treatments Coverage Comprehensive, virtual 75% of clinicians care for hundreds of are
Slide 10: Experts In Marketing & Analytics
NASDAQ: LFMD Experts In Marketing & Analytics Proprietary technology platform that enables flexible acquisition strategies ~130 person call center in Greenville, SC that drives new acquisition and high touch patient care Custom built analytics platform that enables real- time reporting and decision
Slide 11: Proprietary & Scalable Tech Stack
NASDAQ: LFMD Proprietary & Scalable Tech Stack Designed to support a diverse portfolio of DTC and B2B telehealth product and service offerings Integrations with Quest, LabCorp, EMR, multiple pharmacies, in-home tools, symptom checker, prescription discount card, and more Designed with a compliance-f
Slide 12: Rapidly Expanding Telehealth Presence
NASDAQ: LFMD Rapidly Expanding Telehealth Presence 2019 2021 2022 DTC Telemedicine Virtual Primary Care B2B Solutions Subscription-based Services include primary care, Digital front-door treatment+Rx offerings urgent care, and chronic strategies for healthcare condition management product companies
Slide 13: Our Telehealth Brands
NASDAQ: LFMD Our Telehealth Brands ~$250B ~$44B ~$13.5B >$5.1B ~$2.8B market size market size market size market size market size ® ® Primary Care Dermatology Allergy & Asthma Men’s Health Hair Loss Primary care, urgent Dermatology Treatment, prescription Discreet and fast Treatment, care, chronic c
Slide 14: WorkSimpli
NASDAQ: LFMD WorkSimpli Overview: Leading global provider of workplace and document services solutions ranging including pdf, HR and document services. Over 170K subscribers worldwide. Stand-alone business that operates separate from LifeMD while providing valuable cash flow back to LifeMD and is se
Slide 15: LifeMD Virtual Primary Care Has Hit Its Stride
NASDAQ: LFMD LifeMD Virtual Primary Care (VPC) Has Hit Its Stride And Is Rapidly Expanding End of Period LifeMD VPC Patients 18000 16000 14000 12000 VPC Patients 11,000 10000 8000 7,000 6000 4000 2,400 2000 1,000 420 0 Jun-22 Jul-22 Q3 22 Q4 22 Q1 23A 15
Slide 16: Early Mover Advantage Has Enabled Incredible Growth
NASDAQ: LFMD $140-$150M Early Mover Advantage, Supported By A Patient-Centric Approach, Has Enabled Incredible Growth $119M $36M $140M - $150M $93M 2023E Revenue Forecast $25M 18% - 26% $83M YoY Estimated Revenue $37M Growth in ‘23 $68M $7M $13M $30M 715K+ $11M $2M Patients & Customers To-Date 2019A
Slide 17: Achieved Profitability in Q4 '22, Meaningful Growth Ahead
NASDAQ: LFMD Achieved Profitability in Q4 ‘22, Meaningful Growth Ahead Annual Consolidated Adjusted EBITDA ($ millions) $12-$18M 2023E ($15)M ($38)M 2022 2021 Note: Consolidated Adjusted EBITDA includes Telehealth and WorkSimpli results. 17
Slide 18: Rapidly Accelerating Gross Margins And Increasing Leverage On Marketing Spend
NASDAQ: LFMD Rapidly Accelerating Gross Margins And Increasing Leverage On Marketing Spend Driving Continued Growth In Profitability Consolidated Gross Margin % Marketing Expenses as % of Sales 35 125% 90% 88% 32 100% Net Revenue ($ Millions) 86% 77% 75% 84% 72% 29 75% 62% 82% 55% 50% 80% 26 50% 78%
Slide 19: Full Year 2023 Guidance Reflecting Substantial Profitability Growth
NASDAQ: LFMD Full Year 2023 Guidance Reflecting Substantial Profitability Growth FY 2023 GUIDANCE FY 2022 ACTUAL DELTA % Consolidated Net Revenue $140-$150 million $119 million +18-26% Gross Margin % 87% 84% +300 bps Consolidated Adj. EBITDA $12-$18 million $(15) million +180-220% Free Cash Flow Bre
Slide 20: Strong Liquidity to Meet our Capital and Growth Needs
NASDAQ: LFMD Strong Liquidity to Meet our Capital and Growth Needs FY 2023 CASH FLOW GUIDANCE End of Year 2022 Actual Cash Balance $4 million Plus Avenue Capital FY23 Debt Proceeds, net +$18 million Operating Cash Flow (incl. Interest Expense) +$4-$8 million Less Capex $(6)-$(8) million Less Preferr
Slide 21: Management Team and Board of Directors
NASDAQ: LFMD Management Team Justin Schreiber Alex Mironov Marc Benathen Stefan Galluppi Brad Roberts Jessica Friedeman Chief Executive President Chief Financial Officer Chief Innovation & Chief Operating Officer Chief Marketing Officer Officer Marketing Officer Dr. Tony Puopolo James Porte Eric Yec
Slide 22: Investor Highlights
NASDAQ: LFMD Investor Highlights Significant presence within massive and growing addressable markets Proprietary technology platform differentiated by leading 50-state, affiliated physician network High margin products/services generating 85%+ consolidated gross margins EBITDA break-even with signif
Slide 23: Company Contact
Company Contact Marc Benathen [email protected]